For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Agy Therapeutics, Inc.

USPTO Granted Patents = 13

Forward Citations = 213

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Daniel J Chin (8 out of 11 patents)

Thorsten Melcher (7 out of 7 patents)

Mirella Gonzalez-Zulueta (4 out of 5 patents)

4. Sabine Mueller (3 out of 4 patents)

5. Tadeusz Wieloch (2 out of 3 patents)

6. Li Gan (2 out of 10 patents)

7. Donna Hendrix (2 out of 2 patents)

8. Kalev Kask (2 out of 2 patents)

9. Keith McFarland (1 out of 18 patents)

10. Roman Urfer (1 out of 5 patents)

11. Erik Damien Foehr (1 out of 5 patents)

12. Richa Wilson (1 out of 9 patents)

13. Donna Oksenberg (1 out of 3 patents)

14. Shu-Gui Huang (1 out of 1 patent)

15. Shiming Ye (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 7060275 - Use of protein biomolecular targets in the treatment and visualization of brain tumors (2006-06-13),

2. 7014838 - Use of biomolecular targets in the treatment and visualization of brain tumors (2006-03-21),

3. 6977142 - High-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity (2005-12-20),

4. 6924109 - High-throughput transcriptome and functional validation analysis (2005-08-02),

5. 6876930 - Automated pathway recognition system (2005-04-05),

6. 6846641 - In vitro ischemia model (2005-01-25),

7. 6841351 - High-throughput transcriptome and functional validation analysis (2005-01-11),

8. 6670138 - Method of diagnosing ischemic stroke via UCP-2 detection (2003-12-30),

9. 6660483 - Diagnostic marker for neurological conditions (2003-12-09),

10. 6586239 - Purifying microglial cells by binding cell Fc receptor to immunoglobulin G Fc domain (2003-07-01),

11. 6521414 - Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 (2003-02-18),

12. 6470277 - Techniques for facilitating identification of candidate genes (2002-10-22),

13. 6455026 - Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors (2002-09-24),

AGY Therapeutics, Inc. is a biotechnology company focused on developing innovative therapeutics to address unmet medical needs. With a diverse portfolio of drug candidates, AGY is dedicated to advancing groundbreaking treatments in areas such as neurological disorders, oncology, and rare diseases. Through extensive research and collaboration with leading experts, AGY aims to improve patient outcomes and enhance quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#80 in South San Francisco, CA

#5,489 in California

#23,150 in US

#43,682 in the World

South San Francisco, CA, United States of America

Agy Therapeutics, Inc.

Forward Citations = 213

24 inventors:

Daniel J Chin (8 out of 11 patents)

Thorsten Melcher (7 out of 7 patents)

Mirella Gonzalez-Zulueta (4 out of 5 patents)

4. Sabine Mueller (3 out of 4 patents)

5. Tadeusz Wieloch (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…